You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL

 

Online download statistics by month:

Online download statistics by month: March 2022 to March 2026

AbstractFullPdf
Mar 2022769804379
Apr 2022391401176
May 2022285294135
Jun 202233534492
Jul 202220120754
Aug 202221522367
Sep 202221321973
Oct 202220320889
Nov 202216316582
Dec 202213613638
Jan 202322422674
Feb 202314114253
Mar 202313213378
Apr 202310210633
May 202312512871
Jun 202313213341
Jul 202311111238
Aug 202310610850
Sep 2023697127
Oct 202310410443
Nov 2023969645
Dec 2023929354
Jan 2024899356
Feb 202410010543
Mar 2024114115176
Apr 2024959654
May 2024888855
Jun 202410410748
Jul 2024878740
Aug 2024939052
Sep 20247980124
Oct 2024909055
Nov 202410911165
Dec 202410610760
Jan 202513513593
Feb 202511611781
Mar 2025878748
Apr 202512312388
May 2025868758
Jun 2025464843
Mar 2026110
Total609362203031